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Abstract
Background: Vascular endothelial apoptosis is significantly associated with atherosclerosis and cardiovascular
diseases, for which oxidized low-density lipoprotein (ox-LDL) is a major risk factor. Allicin, the primary active
ingredient of garlic, has been found to have cardiovascular protective effect by changing the fatty-acid
composition, but its effect on ox-LDL-induced vascular endothelial injury remains unclear. We investigated the
protective effect of allicin on cell viability, LDH release, apoptosis and apoptotic signaling in human umbilical
vein endothelial cells (HUVECs).
Methods: In cultured HUVEC cell line, ox-LDL induced injury was investigated. The cell viability and injury were
evaluated by using cell proliferation Assay kit and LDH release assay. The apoptosis was evaluated by the Annexin
V-FITC kit. The activity of caspase-3 was assessed using a colorimetric caspase-3 assay kit. The ROS production was
evaluated by fluorometric assay and NADPH oxidase activity was assessed with a GENMED kit.
Results: Exposure of HUVECs to ox-LDL (150 μg/ml) reduced cell viability, induced apoptosis and increased activity
of caspase-3, NADPH oxidase, and reactive oxygen species (ROS) production. The pretreatment with allicin (30 and
100 μM) significantly rescued the cell viability, inhibited ox-LDL-induced apoptosis and activity of caspase-3, NADPH
oxidase and ROS production in HUVECs, and the protective effect is concentration-dependent. The allicin (100 μM)
alone did not show significant difference from control. Our study demonstrated that allicin protected HUVECs from
ox-LDL-induced endothelial injury by reducing the apoptosis, mediated by inhibition of caspase-3 and NADPH
oxidase related apoptotic signaling.
Conclusions: Allicin prevents ox-LDL-induced endothelial cell injury by inhibiting apoptosis and oxidative stress
pathway.
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Background
Cardiovascular diseases (CVDs) are medical conditions
often associated with severe outcomes, financial burdens,
and high mortality rate worldwide [1, 2]. It is found that
atherosclerosis significantly involved in the pathogenesis
of CVDs, during which lipids and plaques accumulate in
large arteries [3] and induce endothelial dysfunction dur-
ing the development of atherosclerosis [4]. Endothelial
injuries can be contributed by various factors such as
oxidized low-density lipoprotein (ox-LDL), advanced gly-
cation end-productcs (AGEs), and Angiotensin-2 etc. [5].
Ox-LDL disrupts the antioxidant and secretory activities
of vascular endothelium and induces endothelial apop-
tosis, thus being considered an important risk factor for
endothelia injury [6]. Meanwhile, the increased superoxide
in vessels during oxidative stress facilitates the oxida-
tion of LDL and generates higher amount of ox-LDL,
which cause further detrimental effect on endothelial
functions [7].
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Natural antioxidants from food sources can be whole-
some remedies in preventing and treating atherosclerosis
with relatively smaller side effects, among which garlic
has garnered significant attention because of its cardio-
vascular benefits [8]. Allicin (2-propene-1-sulfinothioic
acid S-2-propenyl ester), the primary active ingredient in
garlic, has been found to produce cardiovascular protection
by changing the fatty acid composition in high-fat-diet mice
and rats [9], while its direct action on ox-LDL-induced vas-
cular endothelial damage remains unknown.
Therefore, we constructed an in vitro oxidative stress
model subjected to ox-LDL-exposure and investigated
the effect of allicin on ox-LDL-induced vascular endo-
thelial injury. Since ox-LDL-induced endothelial cell
apoptosis is significantly involved in the progress of ath-
erosclerosis [10], and because reactive oxygen species
(ROS) play crucial roles in the process of cell apoptosis
[10], we explored the underlying mechanism for the
protective effect of allicin by studying whether it reduces
ox-LDL-mediated ROS production and regulates the ox-
LDL triggered apoptotic pathway such as caspase-3 ex-
pression in endothelia cells.
Methods
Materials
HUVEC cell line was originally acquired from the
American Type Culture Collection (Manassas VA, USA).
Native LDL (nLDL) was purchased from Sigma-Aldrich
(St. Louis, Mo., USA). Dulbecco’s modified Eagle’s media
(DMEM), dimethylsulfoxide (DMSO), and allicin were
obtained from Sigma (St. Louis, MO, USA). LDH assay
kit was purchased from Nanjing Jiancheng Bioengineering
Institute (Nanjing, China). The AnnexinV-FITC kit was
purchased from Invitrogen (Carlsbad, CA, USA). All other
reagents were of analytical grade and purchased from
Sigma-Aldrich (St. Louis, MO, USA).
Preparation of oxLDL [11]
nLDL was incubated with CuSO4 (10 μM) at 37 °C for
24 h. The material was dialyzed against a sterile solution
with NaCl (150 mM), EDTA (1 mM), polymixin B
(100 μg/ml), and pH at 7.4. The presence of oxLDL was
confirmed by agarose gel electrophoresis and the gener-
ation of thiobarbituric acid.
Cell culture and treatment
Endothelial cell line HUVECs were cultured in DMEM
(low glucose) supplemented with 10 % fetal bovine serum,
and maintained in a humidified atmosphere containing
5 % CO2 at 37 °C. The cells between passages 2 and 15
were used in this study.
For the treatment, HUVECs were pre-treated for
20 min with allicin at different concentrations (10, 30,
100 μM) and then exposed to ox-LDL (150 μg/ml) for
the indicated time periods. Since allicin was dissolved in
DMSO, we used 0.1 % DMSO as vehicle control. In our
pilot study, we found that this concentration of DMSO
had no effect on the cells in the presence or absence of
ox-LDL.
Cell viability and LDH release assay [12]
The cell viability was evaluated by using the Cell Titer
96® AQueous One Solution Cell proliferation Assay kit
(Promega Corporation, Madison, WI, USA), which in-
cludes a novel aqueous soluble tetrazolium compound,
MTS, and an electron coupling reagent, phenazine etho-
sulfate. The MTS turns to formazan product by mito-
chondrial dehydrogenase enzymes in active cells. The
formazan product is soluble in the medium and mea-
sured spectrophotometrically at 490 nm. The absorbance
is proportional to the number of viable cells in the cell
culture.
During the treatment, HUVECs were cultured in
96-well plates at a density of 1 × 104 per well and
were allowed to grow to the desired confluence. The
cells were then pre-treated for 20 min with allicin (10 –
100 μM) and then exposed to ox-LDL (150 μg/ml) for
24 h. Cell viability was normalized to the control group.
The LDH released into the media were assessed to deter-
mine LDH activity using an analysis kit according to the
manufacturer’s instructions.
Flow cytometry
The percentage of apoptotic cells was evaluated by flow
cytometry using the Annexin V-FITC kit following
manufacturer’s instructions [13]. Briefly, HUVECs were
cultured in 6-well plates at a density of 2 × 105 cells
per well and treated with allicin (10, 30, 100 μM) for
20 min prior to 24 h of ox-LDL exposure. Attached
cells were harvested by trypsinization and incubated
with annexinV-FITC and propidium iodide (PI) for
15 min at room temperature in the dark. The cell apop-
totic rates were then quantified by flow cytometry.
Measurement of caspase-3 activity
The activity of caspase-3 like protease in the lysate was
assessed using a colorimetric caspase-3 assay kit (Sigma,
St. Louis, MO, USA) according to the manufacturer’s
protocol [14]. In brief, the reaction mixture (total volume,
100 μl) that contained 30 μl of cell lysate and 10 μl of
caspase-3 substrate acetyl–Asp–Glu–Val–Asp–p-nitroa-
nilide (final concentration at 200 μM) in assay buffer was
used, and the assay was performed in 96-well plate. The
mixture was incubated for 90 min at 37 °C and the ab-
sorbance was measured at 405 nm. The caspase-3 activity
was expressed by value of OD405 relative to control,
which was set to 100.
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Measurement of ROS production
The effect of allicin on ROS production in HUVECs was
evaluated by fluorometric assay using DHE as a probe
for the presence of superoxide [14]. After preincubation
for 2 h with allicin at the indicated concentrations,
HUVECs were incubated with DHE for 1 h, followed by
incubation with ox-LDL for 2 h. The fluorescence inten-
sity was measured at 540-nm excitation and 590-nm
emission (before and after exposure to oxLDL) using a
fluorescence microplate reader (Labsystems). The per-
centage increase in fluorescence per well was calculated
by the formula [(Ft2 − Ft0)/Ft0] × 100, where Ft2 is the
fluorescence at 2 h of ox-LDL exposure, and Ft0 is the
fluorescence at 0 min of oxLDL exposure.
Quantitative determination of NADPH oxidase activity by
colorimetric analysis
NADPH oxidase activity was assessed with a GENMED
kit (Genmed Scientifics Inc., Shanghai, China) by colori-
metric method [15]. HUVECs were plated (5 × 106/mL) in
six-well plates with EGM-2 medium containing 2 % FBS.
After 24 h, ox-LDL was added and cells were cultured for
additional 24 h. Thereafter, the protein was extracted from
cells and NADPH oxidase activity was evaluated by
GENMED kit according to the manufacturer’s instruction.
Statistical analysis
All data are presented as mean ± S.D of results from three
independent experiments. The significance of the difference
was analyzed by ANOVA followed by Newman-Student-
Keuls test. A value of P < 0.05 was considered statistically
significant.
Results
Allicin increased cell viability and inhibited LDH release in
ox-LDL-exposed HUVECs
HUVEC cell viability and LDH content in culture
medium were quantified to assess whether allicin protects
endothelial cells from ox-LDL-induced injuries. As shown
in Fig. 1, 24 h of exposure to ox-LDL (150 μg/ml) signifi-
cantly decreased the HUVEC cell viability and promoted
LDH release, compared with normal control (cell viability:
control 100.0 % vs. ox-LDL 54.6 ± 5.4 %; LDH content:
control 23.6 ± 3.3 U/dL vs. ox-LDL 178.5 ± 17.6 U/dL, P <
0.01). The pretreatment with allicin significantly rescued
the cell viability and suppressed the LDH release in a
concentration-dependent manner, which demonstrates
the anti-cytotoxic activity of Allicin. On the other hand,
allicin alone (100 μM) had no effect on cell viability and
LDH release in HUVECs.
Allicin inhibited ox-LDL-induced apoptosis in HUVECs
To investigate the anti-apoptotic effects of allicin on ox-
LDL-exposed HUVECs, annexin V/PI double staining and
flow cytometry analysis were performed. As seen in Fig. 2a
and b (representative images for flow cytometry and the
summarized data), ox-LDL significantly increased the
HUVEC apoptosis rate from 6.6 % to 48.5 % compared
with control (P < 0.01). Pre-treatment with allicin (10, 30,
100 μM) significantly reduced the apoptosis in a
concentration-dependent manner (Fig. 2c). Similar to the
neutral impact on cell viability and LDL release, allicin
(100 μM) alone had no effect on the apoptosis (Fig. 2c).
Subsequently, our study zoomed in on the effect of
allicin on expression of caspase-3, the typical caspase
that plays a central role in cell apoptosis. We found that
normal control endothelial cells had relatively minimal
expression of cleaved caspase-3. However, 24 h of ox-
LDL-exposure markedly increased the expression and
activity of caspase-3 (P < 0.01) (Fig. 2d). Pre-treatment of
endothelial cells with allicin (10–100 μM) inhibited the
ox-LDL-induced caspase-3 activation (Fig. 2d), during
which allicin at higher concentration demonstrated
stronger effect than that of lower concentration, while
allicin (100 μM) alone again had no effect on cleaved
caspase-3 activity.
Fig. 1 Effects of allicin on ox-LDL-induced reduced cell viability and increased LDH release in HUVECs. HUVECs were pre-treated for 20 min with
allicin at different concentrations (10, 30, 100 μM), and then exposed to ox-LDL (150 μg/ml) for 24 h. Cell viability was evaluated by the MTS
method and LDH content in media was measured by assay kit. a Relative cell viability measured by MTS and b LDH content in media. Values are
means ± SD from three independent experiments. **P <0.01 vs. control, #P <0.05, ##P <0.01 vs. ox-LDL
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Allicin suppressed the ROS generation and NADPH
oxidase activation in ox-LDL-exposed HUVECs
Considering the important role of ROS in cell apoptosis,
we examined whether allicin regulates ROS generation
in ox-LDL-exposed HUVECs. By using DHE as a fluor-
escence probe, we assessed the ROS generation and
found that treatment with oxLDL (150 μg/ml) for 2 h in-
creased ROS generation by 3.5-fold, compared with con-
trol cells, whereas the level of ROS in control group was
similar to that in the 100 100 μM allicin treatment group
(Fig. 3a). In addition, the generation of ROS induced by
ox-LDL exposure was inhibited by allicin in a concentra-
tion dependent manner (Fig. 3a).
Since the NOX family of NADPH oxidases represents
one of major source of endothelial ROS production, we
evaluated the effects of allicin on NADPH oxidase
activation in HUVECs after the ox-LDL exposure. We
found that treatment with ox-LDL (150 μg/ml) for 24 h
resulted in a 5.7-fold increase in NADPH oxidase activa-
tion compared with controls, whereas the level of ROS
in control cells was similar to that in 100 μM allicin
treatment group (Fig. 3b). In addition, our result demon-
strated that the NADPH oxidase activation induced by
ox-LDL exposure was inhibited by allicin in a concentra-
tion dependent manner (Fig. 3b).
Discussion
The endothelium dysfunction is a critical early event
in the pathogenesis of atherosclerosis [16]. It is also
known that endothelial apoptosis can destabilize athe-
rosclerotic plaques and lead to thrombosis [17], which
precipitates atherosclerosis, causes acute cardiovascular
symptoms, and complicates CVDs such as coronary artery
disease [18].
Considering the critical role of ox-LDL in the progres-
sion of atherosclerosis and the significance of endothelial
Fig. 2 Inhibitory effects of allicin on ox-LDL-induced HUVECs cell apoptosis and caspase-3 activation. Cells were pre-treated for 20 min with allicin
at different concentrations (10, 30, 100 μM), and were exposed to ox-LDL (150 μg/ml) for 24 h. Cell apoptosis was measured by Flow cytometry.
a, b Flow cytometry dot plot figures of apoptotic cells in control (a) and ox-LDL-exposed group (b). c Rate of apoptotic cells quantified by flow
cytometry. d Caspase-3 activity relative to control that was set as 100. Values are means ± SD from three independent experiments. **P <0.01 vs.
control, #P <0.05, ##P <0.01 vs. ox-LDL
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dysfunction as an early marker during this development
[19], we used ox-LDL-exposed HUVECs as the model to
investigate the endothelial protective effect provided by
allicin.
Ox-LDL disrupts endothelial function such as endo-
thelium secretory activity, antioxidant capabilities and
nitric oxide synthesis, and induces endothelial apoptosis
[20]. Thus, our exploration of the potential mechanism
underlying the endothelial protective effect of allicin
against ox-LDL-induced injury has been focused on its
antioxidant activities, and impact on endothelial apop-
tosis and the major player involved in the apoptosis
pathway.
First of all, our study demonstrated that allicin mark-
edly increased cell viability in ox-LDL-exposed HUVECs
and protected endothelial cells against ox-LDL-induced
apoptosis in concentration-dependent manner. There
are two major apoptosis pathways, one involving death
receptors and the other being intrinsic or mitochondrial
pathway [20]. Caspase-3 activation plays central role for
both apoptotic pathways which converge at proteolytic
activation of caspase-3 [13]. Our study showed that ox-
LDL increased the activity of caspase-3, while we also
observed that allicin decreased ox-LDL-induced caspase-
3 activation, which are consistent with the results that
allicin markedly prevented endothelial cells from ox-
LDL-induced cell apoptosis. Thus, it is suggests that the
anti-apoptotic effect of allicin on vascular endothelial
cells may be mediated by the inhibition of caspase-3
activation.
The ROS production plays pivotal roles in mediating
endothelial cell apoptosis and regulating the develop-
ment of atherosclerosis [21], while NADPH oxidase is a
major source of vascular ROS production, as the enzyme
complex of NADPH oxidases are considered a major
source of superoxide anion formation [22]. In addition,
NADPH oxidase is also heavily involved in endothelial
apoptosis [23]. In present study, we investigated the ef-
fect of allicin on ROS and NADPH oxidase activation in
ox-LDL-exposed endothelial cells. Our results indicate
that allicin suppressed endothelial ROS production and
inhibited the NADPH oxidase activation, which helps
to elucidate the underlying mechanism for the endo-
thelial protective effect of allicin against ox-LDL-induced
injury.
Our study demonstrated that the protective effect of
allicin is concentration-dependent, with higher concen-
tration producing stronger benefits against ox-LDL-
induced damage, but the neutral impact from allicin
(100 μM) alone on either endothelial cell viability or
ROS production suggests that the anti-oxidant and
endothelial protective effects of allicin are responsive to
ox-LDL-induced injury, and the endothelial protection
by allicin is mediated by regulation and inhibition of ox-
LDL-triggered apoptotic signaling, which helped to
elucidate the underlying mechanism of action of allicin
and reinforced its significance as a new therapeutic
agent for atherosclerosis and CVDs for which ox-LDL is
a major risk factor.
There are some limitations in this work. Fristly, only
ox-LDL HUVECs model was used. Whether allicin pro-
tects vascular endothelial cells from other risk factors of
vascular diseases remains to be investigated further.
Secondly, we only investigate inhibition of allicin on
apoptosis and oxidative stress. Further mechanism
should be further investigated. Thirdly, we only invested
protection of allicin in vitro model. When resources
allows, we will expand the study and include the investi-
gation on in vivo models.
Conclusions
Allicin protects vascular endothelial cells against ox-LDL-
induced cell death by inhibiting the apoptotic pathway
and anti-oxidative stress.
Fig. 3 Inhibitory effect of allicin on ox-LDL-induced ROS overproduction and NADPH oxidase activation. a After pre-treated with allicin (10, 30,
100 μM) for 20 min, cells were exposed to ox-LDL (150 μg/mL) for 2 h followed by a 1-h incubation with superoxide-sensitive fluorescent probe
DHE (10 μM). Fluorescence intensity of cells was measured with a fluorescence microplate reader. Fluorescence distribution of DHE oxidation is
expressed as a percentage of increased intensity. b Allicin attenuated the level of NADPH oxidase activation. HUVECs were pretreated with allicin
at indicated concentrations for 2 mins followed by 24 h of ox-LDL (150 μg/mL) exposure. NADPH oxidase activity was determined by colorimetric
analysis. Values are means ± SD from three independent experiments. **P <0.01 vs. control, #P <0.05, ##P <0.01 vs. ox-LDL
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